Retatrutide
A triple hormone receptor agonist (GIP/GLP-1/Glucagon) that produces 24% weight loss through synergistic appetite suppression and thermogenesis.
Also known as: LY3437943, Triple Agonist GIP/GLP-1/Glucagon
Available on Forge Amino
Retatrutide — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Activates three complementary energy pathways: GIPR reduces appetite and modulates lipolysis; GLP-1R delays gastric emptying and increases satiety; GCGR increases hepatic glucose production and brown adipose tissue thermogenesis.
Key Benefits
- ✓24% average weight loss (52 lbs / 24 kg)
- ✓Superior lean mass preservation vs GLP-1 alone
- ✓Enhanced HbA1c reduction in diabetics
- ✓Improved triglycerides and lipid profile
- ✓Increased resting energy expenditure
Dosing Protocols
Beginner / Intermediate
Dose
1-4 mg
Frequency
Once weekly subcutaneous
Cycle Length
12+ weeks with dose escalation
Notes
Start at 1 mg, escalate gradually (~0.5-1 mg) every 4 weeks
Advanced
Dose
8-12 mg
Frequency
Once weekly subcutaneous
Cycle Length
24-48 weeks
Notes
Maintenance at 12 mg achieves maximum weight loss
Side Effects & Safety
Common Side Effects
- Nausea (25-35% during escalation phase)
- Vomiting (8-12%)
- Diarrhea (15-20%)
- Constipation (10-15%)
- Most resolve by weeks 2-4 at each dose
Contraindications
- Personal or family history of medullary thyroid carcinoma
- MEN2 syndromes
- History of acute or chronic pancreatitis
- Type 1 diabetes (relative)
- Diabetic ketoacidosis history
- End-stage renal disease
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Amplify weight loss with triple mechanism: Retatrutide activates appetite suppression, fat breakdown, and thermogenesis simultaneously.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.